GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

GETI.B

184.85

+0.33%↑

EKTA.B

54.35

-3.81%↓

ATT

+0.2%↑

AMBEA

128.6

+0.78%↑

ARJOB

25.2

+1.12%↑

Home・Aandelen Lijst・Orexo AB

O
Orexo AB

Gesloten

21.95 3.29

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

22.7

Belangrijke statistieken
By Trading Economics
Inkomsten	-68M -116M
Verkoop	-115M 3.3M
EPS	20.884
Winstmarge	-3,503.03
Werknemers	72
EBITDA	-262M -272M

Dividenden
By Dow Jones
Volgende Winsten	28 apr 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-255M 779M
Vorige openingsprijs	18.66
Vorige sluitingsprijs	21.95

Orexo AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 mrt 2026, 18:58 UTC

Belangrijke Marktbewegers

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24 mrt 2026, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 mrt 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24 mrt 2026, 23:16 UTC

Marktinformatie

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24 mrt 2026, 22:40 UTC

Winsten

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24 mrt 2026, 21:44 UTC

Marktinformatie

Global Equities Roundup: Market Talk

24 mrt 2026, 21:44 UTC

Marktinformatie

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24 mrt 2026, 20:59 UTC

Winsten

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24 mrt 2026, 20:58 UTC

Belangrijke Nieuwsgebeurtenissen

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

24 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

24 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

24 mrt 2026, 20:25 UTC

Winsten

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24 mrt 2026, 20:15 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Commodities Roundup: Market Talk

24 mrt 2026, 20:10 UTC

Marktinformatie

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q Sales $378.7M >WOR

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q Adj EPS 98c >WOR

24 mrt 2026, 20:10 UTC

Winsten

Worthington Enterprises 3Q EPS 92c >WOR

24 mrt 2026, 19:25 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24 mrt 2026, 19:06 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24 mrt 2026, 18:51 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24 mrt 2026, 18:40 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

24 mrt 2026, 18:40 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24 mrt 2026, 18:34 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24 mrt 2026, 18:27 UTC

Marktinformatie

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24 mrt 2026, 18:21 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Silver Snaps 9-Session Losing Streak -- Market Talk

24 mrt 2026, 18:00 UTC

Acquisities, Fusies, Overnames

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Peer Vergelijking

Prijswijziging

Orexo AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.